Naoki Amada
Impact in
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
- Treatment of Major Depression
- Biological Psychiatry top 10%
Papers in
-
- Neuroscience and Neuropharmacology Research 5
- Neurotransmitter Receptor Influence on Behavior 4
-
- Cannabis and Cannabinoid Research 3
- Cholinesterase and Neurodegenerative Diseases 2
- Treatment of Major Depression 2
- Co-authors
- Yuki Yamasaki (3 shared papers)Tetsuro Kikuchi (5 shared papers)Akihito Watanabe (3 shared papers)Haruhiko Sugino (4 shared papers)Kenji Maeda (6 shared papers)Gernot Riedel (2 shared papers)Hitomi Akazawa (3 shared papers)Serena Deiana (2 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Behavioural Pharmacology (1 paper)The Journal of Biochemistry (1 paper)Clinical Therapeutics (1 paper)Neuroreport (1 paper)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Naoki Amada
13 papers receiving 905 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 564
- Biological Psychiatry 58
- Psychiatry and Mental health 322
- Cellular and Molecular Neuroscience 366
- Behavioral Neuroscience 27
Countries citing papers authored by Naoki Amada
This map shows the geographic impact of Naoki Amada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Amada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Amada more than expected).
Fields of papers citing papers by Naoki Amada
This network shows the impact of papers produced by Naoki Amada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Amada. The network helps show where Naoki Amada may publish in the future.
Co-authors
The 25 scholars most cited alongside Naoki Amada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 305 | |
| 2 | 2014 | 278 | |
| 3 | 2014 | 109 | |
| 4 | 2013 | 68 | |
| 5 | 2005 | 44 | |
| 6 | 2015 | 34 | |
| 7 | 2015 | 32 | |
| 8 | 2016 | 20 | |
| 9 | 2019 | 19 | |
| 10 | 2023 | 7 | |
| 11 | 2003 | 6 | |
| 12 | 2022 | 3 | |
| 13 | 2024 | 2 |
About Naoki Amada
Naoki Amada is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Psychiatry and Mental health, Cognitive Neuroscience and Physiology, having authored 13 papers that have together received 927 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Alzheimer's disease research and treatments (3 papers), Memory and Neural Mechanisms (3 papers), Schizophrenia research and treatment (3 papers), Cannabis and Cannabinoid Research (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Treatment of Major Depression (2 papers). The work is most often cited by research in Pharmacology (564 citations), Biological Psychiatry (58 citations), Psychiatry and Mental health (322 citations), Cellular and Molecular Neuroscience (366 citations) and Behavioral Neuroscience (27 citations). Naoki Amada has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Yuki Yamasaki, Tetsuro Kikuchi, Akihito Watanabe, Haruhiko Sugino, Kenji Maeda, Gernot Riedel, Hitomi Akazawa, Serena Deiana, Tine B. Stensbøl and Christoffer Bundgaard. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Behavioural Pharmacology, The Journal of Biochemistry, Clinical Therapeutics and Neuroreport.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.